Join us at the 16th International Scientific Conference on Probiotics, Prebiotics, Gut Microbiota and Health – IPC2023, taking place from June 20-22, 2023, at the Carlton Hotel in beautiful Bratislava, Slovakia
Are you passionate about the fascinating world of gut microbiota and its impact on human health? This is your opportunity to immerse yourself in cutting-edge research, engage with renowned experts, and be part of groundbreaking discussions that shape the future of healthcare!
Our R&D Scientist – Health & Nutrition Business Unit, Valentina Taverniti will be addressing the conference on the 22nd during Gut-Health Axis session with the scientific review “Gut microbiota modulation by probiotics improves inflammaging”.
ABSTRACT:
The health benefits of probiotics are not limited to the gut. Among the many mechanisms on how these systemic health benefits arise, the modulation of the gut microbiota composition through probiotic intake is an important one, as it can impact the metabolic milieu in the gut, and thus regulate specific host cell pathways and responses. In this context, we present a clinical study focused on the use of a well-characterized combination of probiotic strains L. rhamnosus IMC 501® and L. paracasei IMC 502®, named SYNBIO®, that can improve inflammaging and the nutritional status of the elderly.
Latest News
An important regulatory goal has been achieved with the conclusion reached by an independent expert panel for the self-affirmed GRAS (Generally Recognized as Safe) determination of our postbiotic CRL1505® HI.
The global population is ageing faster than ever before. In 2019, life expectancy at birth reached 72.8 years almost 9 years more than in 1990. In this context, staying healthy
“Survivability of probiotic CA15 strain with and without fluconazole co-administration and its effect on gut microbiota and metabolome through SHIME® model” is the title of the study that has been
GRAS (Generally Recognised as Safe) is a designation by the US Food and Drug Administration (FDA) that indicates that a substance is considered safe based on expert consensus or a
Brisbane, 8 January 2025 Sacco System Australia, a leader in innovative probiotic and postbiotic solutions, is proud to announce that L. rhamnosus CRL 1505 HI (heat-inactivated) and Lactobacillus acidophilus LA1
Nous sommes fiers de présenter la cinquième édition de notre rapport de durabilité, une occasion de réfléchir sur les réalisations atteintes et les défis à venir…
Today in the presence of Luna Angelini Marinucci, from 2022 the Consul of Italy in Brisbane, with territorial jurisdiction over the State of Queensland and over the Northern Territory the
At Sacco System we have always put Sustainability at the very core of our activities and our commitment, which is why we are proud that our companies Caglificio Clerici, Sacco
Indianapolis, Ind., and Yeerongpilly, Queensland, Australia, March 13, 2024 – List Biotherapeutics, Inc. (List Bio) and Sacco System Australia Pty Ltd (Sacco) today announced a lead share agreement to introduce
Sacco System est le pôle biotechnologique international dédié à l’industrie alimentaire, nutraceutique pharmaceutique, basé sur la tradition…
We are proud to announce that Sacco System has made a significant donation in support of Action4Diabetes (A4D), mission—a UK-based charity committed to ensuring free access to crucial medical supplies,
This year too, SACCO SYSTEM proudly participates in the Deploy Your Talents (DYT) project, promoted by the Fondazione Sodalitas, with the patronage of the Municipality of Milan and in collaboration